Skip to main content
OpenTrials
Completed

NCT Number: NCT02977793

Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL

The Tomey EM-4000 Specular Microscope is designed to observe and analyze corneal endothelium.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

About this study

The Tomey EM-4000 Specular Microscope is designed to observe and analyze corneal endothelium by capturing an image of corneal endothelium tissues. without making contact, analyzing the captured image, and calculating data such as cell density.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Non-pathologic young adults (18-28 years old) and non-pathologic adults (29-80 years old)

  • Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
  • Subjects who agree to participate in the study.

Inclusion criteria

-Pathologic adults (29-80 years old):

  • Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
  • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
  • Subjects who agree to participate in the study;
  • At least one eye with any of the following conditions:
  • History of post-op surgical trauma including pseudophakic or aphakic bullous keratopathy
  • History of corneal transplant
  • Physical injury or trauma to the cornea
  • Fuch's dystrophy, Guttata or other corneal endothelial dystrophies
  • Keratoconus
  • Long-term polymethyl methacrylate (PMMA) contact lens use (greater than 3 years).

Exclusion criteria

- Non-pathologic young adults (18-28 years old) and non-pathologic adults (29-80 years old)

  • History of post-op surgical trauma including bullous keratopathy;
  • History of corneal transplant;
  • Evidence of physical injury or trauma to the cornea;
  • Fuch's dystrophy, Guttata or other corneal endothelial dystrophies;
  • Keratoconus;
  • Long-term PMMA contact lens use (greater than 3 years);
  • History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device;
  • Fixation problems which may prevent obtaining good Tomey EM-4000 and Konan CellChek XL images in either eye.

Exclusion criteria

- Pathologic adults (29-80 years old)

  • History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device;
  • Fixation problems which may prevent obtaining at least poor quality Tomey EM-4000 and Konan CellChek XL images in either eye.

Treatment and study plan

Tomey EM-4000 Specular Microscope

Device

Konan CellChek XL Specular Microscope

Device

Primary outcomes

  1. Endothelial cell density measurements

    Time frame: 1 day

  2. Coefficient of variation of endothelial cell area

    Time frame: 1 day

  3. % Hexagonality

    Time frame: 1 day

  4. Central Corneal Thickness

    Time frame: 1 day

Secondary outcomes

  1. Adverse Events

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Tomey Corporation

Industry

Registry information

Official study title

Comparative Study of the TOMEY Specular Microscope EM-4000 and the Konan CellChek XL for the Measurements of Endothelial Cell Density, Coefficient of Variation of Endothelial Cell Area, % Hexagonality, Central Corneal Thickness

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 30, 2016
Registry last updated
Aug 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.